Patents by Inventor Takaaki Nishioka

Takaaki Nishioka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20230338386
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20220378797
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: July 29, 2022
    Publication date: December 1, 2022
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20210196722
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: March 12, 2021
    Publication date: July 1, 2021
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 10973827
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: April 13, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20200069693
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • Surface-treated calcium carbonate filler for curable resin composition, and curable resin composition containing filler
    Patent number: 10336888
    Abstract: Provided are a surface-treated calcium carbonate filler useful in a curable resin, for imparting performance having excellent heat resistance, color fastness, strength and elongation, and a curable resin containing the filler. A surface-treated calcium carbonate filler for a curable resin composition, in which calcium carbonate synthesized using compact limestone is treated by a surface treatment agent, the surface-treated calcium carbonate filler satisfying the following formulae (1) to (4): 0?Mg?2000,??(1) 0?Fe?200,??(2) 70?SFa?100, and??(3) 0?Ufa?30,??(4) Mg: a proportion [ppm] of magnesium contained in surface-treated calcium carbonate, Fe: a proportion [ppm] of iron contained in surface-treated calcium carbonate, SFa: a proportion [wt %] of saturated fatty acid in the surface treatment agent comprising a water-soluble monovalent salt of a fatty acid, and UFa: a proportion [wt %] of unsaturated fatty acid in the surface treatment agent comprising a water-soluble monovalent salt of a fatty acid.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: July 2, 2019
    Assignee: MARUO CALCIUM CO., LTD.
    Inventors: Ryoji Utsumi, Shigeru Sakaguchi, Takaaki Nishioka
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20180289716
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 10022379
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: July 17, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • Engine
    Patent number: 9982591
    Abstract: An object is to provide an engine in which the exhaust manifolds capable of switching a dynamic pressure supercharging method and a static pressure supercharging method can be easily changed to the exhaust manifolds only of the dynamic pressure supercharging method or only of the static pressure supercharging method without replacing exhaust manifolds themselves. In an engine in which a plurality of independent exhaust manifolds is respectively connected to a supercharger, end parts of the exhaust manifolds are coupled to each other by one or more coupling pipes, an on/off valve that brings the exhaust manifolds into an independent state is provided each of in the coupling pipes, and the coupling pipe is configured such that a part including the on/off valve or the on/off valve is detachable from the exhaust manifolds.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: May 29, 2018
    Assignee: Yanmar Co., Ltd.
    Inventors: Takaaki Nishioka, Hirofumi Yukawa, Hiroki Tanaka, Kenya Onishi
  • SURFACE-TREATED CALCIUM CARBONATE FILLER FOR CURABLE RESIN COMPOSITION, AND CURABLE RESIN COMPOSITION CONTAINING FILLER
    Publication number: 20180016421
    Abstract: Provided are a surface-treated calcium carbonate filler useful in a curable resin, for imparting performance having excellent heat resistance, color fastness, strength and elongation, and a curable resin containing the filler.
    Type: Application
    Filed: March 18, 2016
    Publication date: January 18, 2018
    Applicant: MARUO CALCIUM CO., LTD.
    Inventors: Ryoji UTSUMI, Shigeru SAKAGUCHI, Takaaki NISHIOKA
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20170119773
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: January 11, 2017
    Publication date: May 4, 2017
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20160310435
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: July 7, 2016
    Publication date: October 27, 2016
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • ENGINE
    Publication number: 20160265423
    Abstract: An object is to provide an engine in which the exhaust manifolds capable of switching a dynamic pressure supercharging method and a static pressure supercharging method can be easily changed to the exhaust manifolds only of the dynamic pressure supercharging method or only of the static pressure supercharging method without replacing exhaust manifolds themselves. In an engine in which a plurality of independent exhaust manifolds is respectively connected to a supercharger, end parts of the exhaust manifolds are coupled to each other by one or more coupling pipes, an on/off valve that brings the exhaust manifolds into an independent state is provided each of in the coupling pipes, and the coupling pipe is configured such that a part including the on/off valve or the on/off valve is detachable from the exhaust manifolds.
    Type: Application
    Filed: October 22, 2014
    Publication date: September 15, 2016
    Inventors: Takaaki NISHIOKA, Hiroshi YUKAWA, Yuki TANAKA, Kenya ONISHI
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 9415016
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: August 16, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20150366812
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: August 27, 2015
    Publication date: December 24, 2015
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 9155705
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: October 13, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • Sustained-release preparations of quinolone antibiotics
    Patent number: 8187632
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: May 29, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stab, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20110206766
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: April 2, 2009
    Publication date: August 25, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • Method of preparing sustained-release preparations of quinolone antibiotics
    Patent number: 7780986
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: August 24, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stab, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • Sustained-release preparations of quinolone antibiotics and method for preparation thereof
    Patent number: 7709022
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: May 4, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Staβ, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi